“When it is, accordingly, proved by all sorts of committees that AstraZeneca, as in any clinical study, exists that he died from the vaccine, it will be bad for the vaccine.

Until this has been proven, I can only regret the death of this person, ”RIA Novosti quotes Gunzburg.

According to him, if the trials were continued, it means that the company has "serious evidence and reasons not to link death" and vaccinations.

Earlier it was reported that a participant in a trial of a vaccine against COVID-19, developed by AstraZeneca and the University of Oxford, died in Brazil from complications caused by coronavirus.

At the end of September, the Director General of the World Health Organization (WHO) Tedros Adhanom Ghebreyesus said that about 200 coronavirus vaccines are in clinical and preclinical trials.